Growing evidence of the safety of JAK inhibitors in patients with rheumatoid arthritis

Rheumatology
Masayoshi Harigai

Abstract

To facitinib and baricitinib are two of the currently available Janus kinase (JAK) inhibitors for the treatment of patients with RA. Randomized controlled trials have shown that these JAK inhibitors are as efficacious as biological DMARDs. Safety profiles of these JAK inhibitors in randomized controlled trials and their long-term extension studies have been demonstrated; however, real world evidence remains to be established to bridge the gap between randomized controlled trials and rheumatology clinics. Fundamentally, no difference in the screening, prevention, and monitoring of infections between JAK inhibitors and biological DMARDs exists. However, increased risk of herpes zoster is probably common to all JAK inhibitors. No indication of increased risk for malignancy in patients with RA treated with JAK inhibitors has been reported. To evaluate risks of relatively rare serious adverse events such as thromboembolic events, gastrointestinal perforation, and interstitial lung disease in clinical settings, accumulation of cases with these events are needed. Continuous pharmacovigilance activity is absolutely warranted to establish the safety of JAK inhibitors in patients with RA and other rheumatic diseases.

References

Jul 14, 2006·Annals of the Rheumatic Diseases·T YamadaH Yamanaka
Nov 6, 2007·The New England Journal of Medicine·Masayoshi HarigaiUNKNOWN Pneumocystis Pneumonia under Anti-Tumor Necrosis Factor Therapy (PAT) Study Group
Mar 27, 2009·Rheumatology·Tetsuji SawadaUNKNOWN Study Committee for Leflunomide-induced Lung Injury, Japan College of Rheumatology
Aug 5, 2009·Rheumatology·Takeo SatoUNKNOWN Study Committee for Leflunomide-induced Lung Injury, Japan College of Rheumatology
Sep 3, 2011·Arthritis Research & Therapy·Michael H SchiffRonald F van Vollenhoven
May 12, 2012·Arthritis and Rheumatism·Cynthia S CrowsonEric L Matteson
Sep 6, 2012·JAMA : the Journal of the American Medical Association·Maria A Lopez-OlivoMaria E Suarez-Almazor
Nov 10, 2013·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·W-M KeA W F On
Jun 17, 2015·Nature Reviews. Cardiology·John A Heit
Aug 15, 2015·Arthritis Research & Therapy·Teresa A SimonSamy Suissa
Jun 11, 2016·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Megan E B ClowseAmy Marren
Jul 23, 2016·Seminars in Arthritis and Rheumatism·Christina Charles-SchoemanRichard Riese
Mar 3, 2017·Nature Reviews. Rheumatology·Kevin L Winthrop
Aug 29, 2017·Arthritis & Rheumatology·Kevin L WinthropEustratios Bananis
Sep 25, 2017·Arthritis Care & Research·Xavier MarietteMary G Boy
Feb 8, 2018·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Cheryl NeslusanLien Vo

❮ Previous
Next ❯

Citations

Jan 4, 2020·Clinical Rheumatology·Elisabetta MiserocchiRolando Cimaz
Mar 17, 2020·Expert Opinion on Drug Safety·Suguru Honda, Masayoshi Harigai
Jun 6, 2020·Immunological Medicine·Akio Morinobu
Jun 15, 2020·Allergy·Carmen RiggioniCezmi A Akdis
Mar 30, 2020·Medicine·Daisuke TsukuiKoichi Hirata
Jun 17, 2020·BMC Immunology·Yuya FujitaKiyoshi Migita
Jun 17, 2020·Therapeutic Advances in Hematology·Ramzi AbboudJohn F DiPersio
Jun 5, 2020·Journal of Neurovirology·Peter Ge Kennedy, Trine H Mogensen
Jul 14, 2020·Frontiers in Immunology·Serena ColafrancescoRoberta Priori
Jul 3, 2019·Case Reports in Rheumatology·Georgio MedawarRabih Said
Apr 30, 2020·Alimentary Pharmacology & Therapeutics·Aysha H Al-AniBritt Christensen
Jun 20, 2020·Clinical Reviews in Allergy & Immunology·Jiao JiangQianjin Lu
Sep 20, 2020·Inflammopharmacology·Genu GeorgeK G Raghu
Apr 16, 2020·Journal of Clinical Medicine·Giulia CassoneMarco Sebastiani
Jun 5, 2020·Nature Reviews. Rheumatology·Anne Grete SembSilvia Rollefstad
Oct 8, 2020·The Journal of Dermatological Treatment·Marco BoeriMarco Di Bonaventura
Nov 28, 2020·Postgraduate Medicine·Sairaj SatarkerMadhavan Nampoothiri
Nov 14, 2020·Clinical Reviews in Allergy & Immunology·Hao Li, George C Tsokos
Jan 31, 2021·Lancet·Kamran GhoreschiRobert Sabat
Feb 5, 2021·Journal of Clinical Medicine·Peter C TaylorJanet Pope
Apr 23, 2020·Journal of Autoimmunity·Carlo PerriconeRoberto Gerli
Nov 2, 2020·The Journal of Allergy and Clinical Immunology·William DamskyBrett King
Mar 30, 2021·Expert Review of Clinical Immunology·Andreina ManfrediMarco Sebastiani
Apr 9, 2021·Annals of Clinical Microbiology and Antimicrobials·Matic MihevcIztok Holc
Apr 10, 2021·Nature Reviews. Rheumatology·Fabiola AtzeniZoltán Szekanecz
Mar 28, 2021·Joint, Bone, Spine : Revue Du Rhumatisme·Joanna KedraRaphaèle Seror
Apr 14, 2021·Expert Review of Clinical Pharmacology·Maria Gabriella RaimondoEnnio Giulio Favalli
Apr 23, 2021·Autoimmunity Reviews·Esther F Vicente-RabanedaMiguel Á González-Gay
Apr 23, 2021·Journal of Gastroenterology·Hiroshi NakaseKazuhiko Koike
May 6, 2021·Rheumatology·Benjamin ClarkeJames Galloway
May 13, 2021·Case Reports in Medicine·Caterina VacchiMarco Sebastiani

❮ Previous
Next ❯

Methods Mentioned

BETA
contraception

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Vestnik dermatologii i venerologii
J VACHTENHEIM
Drug Safety : an International Journal of Medical Toxicology and Drug Experience
Ian C ScottDavid L Scott
Expert Opinion on Pharmacotherapy
Shingo NakayamadaYoshiya Tanaka
© 2022 Meta ULC. All rights reserved